Key keywords: Tyler Mane, X-Men Sabretooth actor, former professional wrestler, super-rare male breast cancer, male breast cancer awareness, celebrity cancer diagnosis, men's health screening, rare cancer research Tyler Mane, the 6’10” performer best known for playing iconic mutant Sabretooth in the 2000 *X-Men* film and a former World Championship Wrestling (WCW) pro wrestler, recently shared a public health update that has shocked fans and sparked urgent conversations about underrecognized men’s health risks. In a video posted to his official Instagram and X (formerly Twitter) accounts earlier this week, Mane revealed he has been diagnosed with a “super-rare” subtype of male breast cancer, a condition that accounts for less than 1% of all breast cancer diagnoses globally, with his specific rare subtype representing fewer than 5% of all male breast cancer cases. Mane explained that he first noticed a small, persistent lump in his chest several months ago, but initially dismissed it as a lingering injury from his decades-long career in contact sports, which included 12 years of professional wrestling and frequent stunt work on film sets. It was only after his wife, actress Renae Geerlings, encouraged him to visit a specialist that he underwent a biopsy and received the diagnosis. “I always thought breast cancer was something that only affected women, like so many guys do,” Mane said in his public statement. “I was embarrassed to even bring it up to my doctor at first, because I felt like it wasn’t a ‘man’s health issue.’ That stigma almost made me wait long enough for this to get a lot worse.” The 57-year-old actor confirmed that he is currently undergoing targeted treatment and that his care team has given him a positive prognosis, as the cancer was caught at an early stage before it spread to other parts of his body. He has pledged to share regular updates about his treatment journey on his social media channels, with the explicit goal of raising awareness for male breast cancer and reducing the stigma that stops many men from seeking timely care for breast-related symptoms. Leading men’s health and breast cancer advocacy organizations have already shared Mane’s story across their platforms, noting that male breast cancer patients are 30% more likely to die from the disease than female patients, largely due to delayed diagnosis caused by low public awareness and lack of routine screening guidelines for men. Mane has also announced that he will be partnering with the Male Breast Cancer Coalition later this year to host fundraisers for rare cancer research and free screening clinics for underserved male populations.